Beta blockers: an overview on the current established therapeutic uses on different classes of patients for a deeper understanding on the proper utilization while prescribing a drug

Abstract

Beta Blockers are one of the most prominent classes of drugs for treating various cardiovascular diseases. It has a wide array of efficacy where the drug has established itself as one of the go-to drugs by physicians for treating hypertension and other conditions. This report is an overview on what we know about Beta Blockers in general and the pharmacology (brief mechanism of action) of the drug. This overview portrays the current established therapeutic uses of the drug. The report comprises the use of beta blockers in arrhythmia, cancer prognosis, chronic heart failure, COPD, sepsis, migraine prevention, cardiomyopathy, myocardial infarction, congestive heart failure and patients undergoing coronary bypass surgery. The findings of its various uses lead report to its second part which contains the in-depth portrayal of its various trials conducted on randomized group, CKD patient groups, elderly patient groups, patient groups with cirrhosis, patients with traumatic brain injury, placebo group study, rate of mortality on beta blocker use. The report also points out the impact of selective and nonselective beta blockers on its long-term use along with potential toxicological outcomes of the drug under various conditions of administration. This report is intended to provide a more concise and medically significant information on beta blockers for aiding in the dosing pattern of the drug. The study will provide a more robust understanding for an impactful therapeutic usage of the drug on different classes of patients.